BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11883506)

  • 21. A phagemid vector using the E. coli phage shock promoter facilitates phage display of toxic proteins.
    Beekwilder J; Rakonjac J; Jongsma M; Bosch D
    Gene; 1999 Mar; 228(1-2):23-31. PubMed ID: 10072755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adapter-directed display: a modular design for shuttling display on phage surfaces.
    Wang KC; Wang X; Zhong P; Luo PP
    J Mol Biol; 2010 Feb; 395(5):1088-101. PubMed ID: 19969002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction.
    Tsafa E; Al-Bahrani M; Bentayebi K; Przystal J; Suwan K; Hajitou A
    Oncotarget; 2016 Aug; 7(32):52135-52149. PubMed ID: 27437775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of efficient RNA interference system using EGF-displaying phagemid particles.
    Jiang H; Cai XM; Shi BZ; Zhang J; Li ZH; Gu JR
    Acta Pharmacol Sin; 2008 Apr; 29(4):437-42. PubMed ID: 18358089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy.
    Larocca D; Baird A
    Drug Discov Today; 2001 Aug; 6(15):793-801. PubMed ID: 11470588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phage versus phagemid libraries for generation of human monoclonal antibodies.
    O'Connell D; Becerril B; Roy-Burman A; Daws M; Marks JD
    J Mol Biol; 2002 Aug; 321(1):49-56. PubMed ID: 12139932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.
    Ju Z; Sun W
    Drug Deliv; 2017 Nov; 24(1):1898-1908. PubMed ID: 29191048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of a filamentous phage display peptide library.
    Fagerlund A; Myrset AH; Kulseth MA
    Methods Mol Biol; 2014; 1088():19-33. PubMed ID: 24146394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Human Osteoarthritic Chondrocytes with Ligand Directed Bacteriophage-Based Particles.
    Chongchai A; Waramit S; Wongwichai T; Kampangtip J; Phitak T; Kongtawelert P; Hajitou A; Suwan K; Pothacharoen P
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin-mediated vectors for gene transfer and therapy.
    Hart SL
    Curr Opin Mol Ther; 1999 Apr; 1(2):197-203. PubMed ID: 11715943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage as gene delivery vectors.
    Monaci P; Urbanelli L; Fontana L
    Curr Opin Mol Ther; 2001 Apr; 3(2):159-69. PubMed ID: 11338929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of phage display in neurobiology.
    Bradbury AR
    Curr Protoc Neurosci; 2010 Apr; Chapter 5():Unit 5.12. PubMed ID: 20373506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eliminating helper phage from phage display.
    Chasteen L; Ayriss J; Pavlik P; Bradbury AR
    Nucleic Acids Res; 2006; 34(21):e145. PubMed ID: 17088290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.
    Romanczuk H; Galer CE; Zabner J; Barsomian G; Wadsworth SC; O'Riordan CR
    Hum Gene Ther; 1999 Nov; 10(16):2615-26. PubMed ID: 10566889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene transfer of Hodgkin cell lines via multivalent anti-CD30 scFv displaying bacteriophage.
    Chung YS; Sabel K; Krönke M; Klimka A
    BMC Mol Biol; 2008 Apr; 9():37. PubMed ID: 18416816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic prostate cancer cell-specific phage-like particles as a targeted gene-delivery system.
    Fagbohun OA; Kazmierczak RA; Petrenko VA; Eisenstark A
    J Nanobiotechnology; 2013 Sep; 11():31. PubMed ID: 24059645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin displayed on filamentous phage as a receptor-specific agonist.
    Rousch M; Lutgerink JT; Coote J; de Bruïne A; Arends JW; Hoogenboom HR
    Br J Pharmacol; 1998 Sep; 125(1):5-16. PubMed ID: 9776337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the synergistic effects of ligand-mediated and phage-intrinsic properties during in vivo selection.
    Driessen WH; Bronk LF; Edwards JK; Proneth B; Souza GR; Decuzzi P; Pasqualini R; Arap W
    Adv Genet; 2010; 69():115-33. PubMed ID: 20807605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries.
    Barry MA; Dower WJ; Johnston SA
    Nat Med; 1996 Mar; 2(3):299-305. PubMed ID: 8612228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.